Solventum Corp. (SOLV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solventum Corp. (SOLV) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.00 Million) by net assets ($4.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Solventum Corp. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Solventum Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SOLV total debt and obligations for a breakdown of total debt and financial obligations.
Solventum Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solventum Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
COLOPLAST SP.ADR 1/10 DK1
F:CBH
|
0.162x |
|
RoboTechnik Intelligent Technology Co Ltd
SHE:300757
|
0.043x |
|
ARC Resources Ltd.
TO:ARX
|
0.084x |
|
GD Power Development Co Ltd
SHG:600795
|
0.123x |
|
Fox Corp Class B
NASDAQ:FOX
|
-0.060x |
|
Lifco AB (publ)
ST:LIFCO-B
|
0.103x |
|
GRAB HOLDINGS LTD CL.A
F:A6I
|
0.010x |
|
Smith & Nephew SNATS Inc
NYSE:SNN
|
0.072x |
Annual Cash Flow Conversion Efficiency for Solventum Corp. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Solventum Corp. from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see Solventum Corp. market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.96 Billion | $1.19 Billion | 0.400x | +143.96% |
| 2023-12-31 | $11.67 Billion | $1.92 Billion | 0.164x | +14.80% |
| 2022-12-31 | $11.74 Billion | $1.68 Billion | 0.143x | -21.69% |
| 2021-12-31 | $12.06 Billion | $2.20 Billion | 0.183x | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advance… Read more